Cubist Systematic Strategies’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,476
Closed -$7.51K 3999
2023
Q1
$7.51K Sell
3,476
-7,052
-67% -$16.2K ﹤0.01% 3737
2022
Q4
$21.6K Buy
+10,528
New +$23.3K ﹤0.01% 3985
2021
Q3
Sell
-32,560
Closed -$138K 3087
2021
Q2
$138K Buy
+32,560
New +$140K ﹤0.01% 2664
2020
Q1
Sell
-10,800
Closed -$73K 2323
2019
Q4
$73K Buy
+10,800
New +$81.2K ﹤0.01% 2244

Other funds holding MNOV

Cubist Systematic Strategies's MNOV Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of MediciNova (MNOV) in Q2 2023, closing a stake of 3,476 shares — an estimated $7.51K sold.

Cubist Systematic Strategies first reported a position in MNOV in Q4 2019 and held it in 4 quarters. The position peaked at $138K in Q2 2021. 34 funds tracked by Wall St. Rank hold MNOV as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining MediciNova position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 3,476 MediciNova shares in Q2 2023, an estimated $7.51K.
  • Cubist Systematic Strategies first reported a position in MediciNova in Q4 2019 and held it in 4 quarters.
  • Cubist Systematic Strategies's MediciNova position peaked at $138K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held MediciNova as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.